Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Small-molecule drugs have been a mainstay of the pharmaceutical industry for nearly a century and they continue to play a crucial role in the industry’s therapeutic arsenal. Advances in technology and ...

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

Learn how to optimize cold chain logistics for biotherapeutics in EMEA and overcome key challenges in delivery and regulation ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Some of the deadliest cancer mutations occur in a gene called KRAS. Drugs that target this gene to stop cancer cells from growing further are known as KRAS inhibitors, which have been regarded as a ...

With one of the most densely concentrated life sciences and biotech ecosystems in Europe, the Netherlands is home to numerous biotech and pharmaceutical companies, and also happens to be the ...

Montreal, the largest city in Canada’s Quebec province, has seen a boom in life sciences over the years. Home to Biotech City, a hub that connects and supports biopharmaceutical companies within the ...